Roivant Sciences Ltd. Common Shares vs Viking Holdings Ltd Ordinary Shares — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $24.72B), while Viking Holdings Ltd Ordinary Shares trades at $81.62 (market cap $36.46B). The key difference: Viking Holdings Ltd Ordinary Shares is the larger of the two by market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Viking Holdings Ltd Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and Viking Holdings Ltd Ordinary Shares for 0 Days on average.
| ROIV | VIK | |
|---|---|---|
Market Cap | $24.72B | $36.46B |
Volume | 6,279,442 | 3,461,906 |
Sector | Health | Consumer Cyclical |
52-Week High | $41.81 | $108.26 |
52-Week Low | $16.04 | $57.08 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $20.99B | $38.84B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →Viking operates river, ocean, and expedition cruises. Its itineraries focus on destination-based travel across Europe, the Americas, and other regions.
Read more on VIK →